Found: 41
Select item for more details and to access through your institution.
Budget Impact Analysis of PCSK9 Inhibitors for the Management of Adult Patients with Heterozygous Familial Hypercholesterolemia or Clinical Atherosclerotic Cardiovascular Disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Health-care utilization and costs with fluticasone propionate and fluticasone propionate/salmeterol in asthma patients at risk for exacerbations.
- Published in:
- Allergy & Asthma Proceedings, 2014, v. 35, n. 1, p. 54, doi. 10.2500/aap.2014.35.3720
- By:
- Publication type:
- Article
Stepping down to fluticasone propionate or a lower dose of fluticasone propionate/salmeterol combination in asthma patients recently initiating combination therapy.
- Published in:
- Allergy & Asthma Proceedings, 2010, v. 31, n. 3, p. 203, doi. 10.2500/aap.2010.31.3359
- By:
- Publication type:
- Article
Adding salmeterol to fluticasone propionate or increasing the dose of fluticasone propionate in patients with asthma.
- Published in:
- Allergy & Asthma Proceedings, 2010, v. 31, n. 3, p. 211, doi. 10.2500/aap.2010.31.3360
- By:
- Publication type:
- Article
Quality-Adjusted Survival with Ribociclib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Postmenopausal Women with HR±HER2- Advanced Breast Cancer in the MONALEESA-3 Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Cost-Effectiveness of Zoledronic Acid Plus Endocrine Therapy in Premenopausal Women With Hormone-Responsive Early Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 4, p. 267, doi. 10.3816/CBC.2010.n.034
- By:
- Publication type:
- Article
Preferences of Canadian Patients and Physicians for Treatment of HR+/HER2-Advanced Breast Cancer.
- Published in:
- Current Oncology, 2021, v. 28, n. 1, p. 491, doi. 10.3390/curroncol28010051
- By:
- Publication type:
- Article
Valsartan versus lisinopril or extended-release metoprolol in preventing cardiovascular and renal events in patients with hypertension.
- Published in:
- American Journal of Health-System Pharmacy, 2007, v. 64, n. 11, p. 1187, doi. 10.2146/ajhp060380
- By:
- Publication type:
- Article
Cost-effectiveness of lapatinib plus capecitabine in women with HER2+ metastatic breast cancer who have received prior therapy with trastuzumab.
- Published in:
- European Journal of Health Economics, 2012, v. 13, n. 5, p. 589, doi. 10.1007/s10198-011-0323-1
- By:
- Publication type:
- Article
Cost utility analysis of early adjuvant letrozole or anastrozole versus tamoxifen in postmenopausal women with early invasive breast cancer: the UK perspective.
- Published in:
- European Journal of Health Economics, 2008, v. 9, n. 2, p. 171, doi. 10.1007/s10198-007-0058-1
- By:
- Publication type:
- Article
The association between adherence to levodopa/carbidopa/entacapone therapy and healthcare utilization and costs among patients with Parkinson's disease: a retrospective claims-based analysis.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Cost-Effectiveness of Pazopanib in Advanced Soft Tissue Sarcoma in the United Kingdom.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Cost-Effectiveness of Pazopanib in Advanced Soft Tissue Sarcoma in the United Kingdom.
- Published in:
- Sarcoma, 2014, p. 1, doi. 10.1155/2014/481071
- By:
- Publication type:
- Article
Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in postmenopausal women with hormone-receptor positive early breast cancer from a Canadian perspective.
- Published in:
- Breast Cancer Research & Treatment, 2008, v. 108, n. 3, p. 375, doi. 10.1007/s10549-007-9607-7
- By:
- Publication type:
- Article
Cost-Effectiveness of Letrozole in the Extended Adjuvant Treatment of Women with Early Breast Cancer.
- Published in:
- Breast Cancer Research & Treatment, 2007, v. 101, n. 1, p. 37, doi. 10.1007/s10549-006-9262-4
- By:
- Publication type:
- Article
Valsartan versus lisinopril or metoprolol to prevent cardiovascular events in patients with hypertension
- Published in:
- 2005
- By:
- Publication type:
- Abstract
Cost-Effectiveness of Lapatinib plus Letrozole in Post-Menopausal Women with Hormone Receptor- and HER2-Positive Metastatic Breast Cancer.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort study.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Utilization of intravenous bisphosphonates in patients with bone metastases secondary to breast, lung, or prostate cancer.
- Published in:
- Supportive Care in Cancer, 2014, v. 22, n. 1, p. 103, doi. 10.1007/s00520-013-1951-z
- By:
- Publication type:
- Article
Cost Effectiveness of Dabrafenib as a First-Line Treatment in Patients with BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma in Canada.
- Published in:
- PharmacoEconomics, 2015, v. 33, n. 4, p. 367, doi. 10.1007/s40273-014-0241-z
- By:
- Publication type:
- Article
Cost effectiveness of once-daily oral chelation therapy with deferasirox versus infusional deferoxamine in transfusion-dependent thalassaemia patients: US healthcare system perspective.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Cost effectiveness of extended adjuvant letrozole in postmenopausal women after adjuvant tamoxifen therapy: the UK perspective.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Survival Outcomes in Patients With Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Receiving Third- or Subsequent Line (3L) Treatment.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S311, doi. 10.1016/j.clml.2017.07.111
- By:
- Publication type:
- Article
Economic burden of disease progression among multiple myeloma patients who have received transplant and at least one line of therapy in the US.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 2, p. 1, doi. 10.1038/s41408-021-00431-5
- By:
- Publication type:
- Article
Lifetime Costs for Treated Follicular Lymphoma Patients in the US.
- Published in:
- PharmacoEconomics, 2021, v. 39, n. 10, p. 1163, doi. 10.1007/s40273-021-01052-3
- By:
- Publication type:
- Article
Cost Effectiveness of Ribociclib in Combination with Fulvestrant for the Treatment of Postmenopausal Women with HR+/HER2− Advanced Breast Cancer Who Have Received No or Only One Prior Line of Endocrine Therapy: A Canadian Healthcare Perspective.
- Published in:
- PharmacoEconomics, 2021, v. 39, n. 9, p. 1045, doi. 10.1007/s40273-021-01027-4
- By:
- Publication type:
- Article
Cost Effectiveness of Ribociclib Plus a Nonsteroidal Aromatase Inhibitor in Pre-/Perimenopausal, HR+ and HER2- Advanced Breast Cancer: A Canadian Healthcare Perspective.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Cost Effectiveness of Blinatumomab Versus Inotuzumab Ozogamicin in Adult Patients with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in the United States.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review.
- Published in:
- Transfusion, 2007, v. 47, n. 10, p. 1919, doi. 10.1111/j.1537-2995.2007.01416.x
- By:
- Publication type:
- Article
Add-On Therapy with Rosiglitazone (RSG)/Metformin (MET) as a Fixed-Dose Combination (FDC) vs RSG plus MET or RSG plus Sulfonylurea (SU) as Separate Pills (SP): Retrospective Study of Outcomes and Costs.
- Published in:
- Diabetes, 2007, v. 56, p. A558
- By:
- Publication type:
- Article
Association Between Use of Thiazolidinediones and Costs of Heart Failure in Patients with Type 2 Diabetes.
- Published in:
- Diabetes, 2007, v. 56, p. A317
- By:
- Publication type:
- Article
Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States.
- Published in:
- American Journal of Hematology, 2008, v. 83, n. 4, p. 263, doi. 10.1002/ajh.21049
- By:
- Publication type:
- Article
Retrospective Study of the Prevalence, Predictors, and Consequences of Nonadherence With Lapatinib in Women With Metastatic Breast Cancer Who Were Previously Treated With Trastuzumab.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Matching-Adjusted Indirect Comparison of Ribociclib Plus Fulvestrant versus Palbociclib Plus Letrozole as First-Line Treatment of HR+/HER2− Advanced Breast Cancer.
- Published in:
- Cancer Management & Research, 2021, v. 13, p. 8179, doi. 10.2147/CMAR.S325043
- By:
- Publication type:
- Article
Overall Survival Endpoint in Oncology Clinical Trials: Addressing the Effect of Crossover - The Case of Pazopanib in Advanced Renal Cell Carcinoma.
- Published in:
- Oncology, 2016, v. 90, n. 3, p. 119, doi. 10.1159/000443647
- By:
- Publication type:
- Article
The Cost of Treatment of Skeletal-Related Events in Patients with Bone Metastases from Lung Cancer.
- Published in:
- Oncology, 2004, v. 67, n. 5/6, p. 390, doi. 10.1159/000082923
- By:
- Publication type:
- Article
Estimating outcomes and cost effectiveness using a single-arm clinical trial: ofatumumab for double-refractory chronic lymphocytic leukemia.
- Published in:
- Cost Effectiveness & Resource Allocation, 2017, v. 15, p. 1, doi. 10.1186/s12962-017-0071-x
- By:
- Publication type:
- Article
From Triple- to Penta-Exposed Multiple Myeloma: A Real-World Study in a Medicare Population.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 3, p. 565, doi. 10.1007/s40487-024-00291-6
- By:
- Publication type:
- Article
Network Meta-analysis of Progression-Free Survival and Overall Survival in First-Line Treatment of BRAF Mutation-Positive Metastatic Melanoma.
- Published in:
- Oncology & Therapy, 2016, v. 4, n. 2, p. 239, doi. 10.1007/s40487-016-0030-2
- By:
- Publication type:
- Article
Cost-effectiveness of pazopanib versus sunitinib for metastatic renal cell carcinoma in the United Kingdom.
- Published in:
- PLoS ONE, 2017, v. 12, n. 6, p. 1, doi. 10.1371/journal.pone.0175920
- By:
- Publication type:
- Article
Cost-effectiveness of alternate strategies for childhood immunization against meningococcal disease with monovalent and quadrivalent conjugate vaccines in Canada.
- Published in:
- PLoS ONE, 2017, v. 12, n. 5, p. 1, doi. 10.1371/journal.pone.0175721
- By:
- Publication type:
- Article